Transgender People and HIV: What We Know
This research brief highlights what we know about HIV and transgender people in the United States.
HIV disproportionately affects members of the LGBTQ+ communities of color, particularly cisgender Black and Latino gay and bisexual, transgender women, and Black women. We are committed to ending the HIV epidemic and HIV-related stigma.
Choose from one of our featured topics to explore specific areas of our HIV & Health Equity resources.
This research brief highlights what we know about HIV and transgender people in the United States.
Here are some things you can do before, during, and after your first visit to discuss PrEP.
PEP is short for Post-Exposure Prophylaxis. It is an HIV prevention strategy that involves taking HIV medications immediately after a single high-risk event.
PrEP is short for Pre-Exposure Prophylaxis, a once-daily pill that reduces the risk of acquiring HIV. It is an FDA-approved prescription medication.
HIV is a virus that attacks your body’s immune system, which is crucial to fighting off infections and diseases. Fortunately, there are now more ways than ever to prevent and…
In January 2023, the Biden administration and the U.S. Food and Drug Administration (FDA) took a significant step toward dismantling antiquated and discriminatory policy preventing gay and bisexual men from…
While HIV affects Americans from all walks of life, the epidemic continues to disproportionately impact certain members of the LGBTQ+ community.
Americans living with HIV or AIDS may face discrimination based on their health status in many areas of life—including employment. Fortunately, federal and state laws protect against discrimination.
Image:
100% of every HRC merchandise purchase fuels the fight for equality.